$8 Million Series A Investment in Kayothera
We are extremely excited to announce the $8,000,000 Series A investment led by Accelerator Life Science Partners (ALSP) in KayoThera,Inc., a FVCG portfolio company. KayoThera, a company developing cancer immunotherapies and a Princeton University spinout, is working to give hope to some of the most vulnerable cancer patients. FVCG provided the initial seed funding to the company in 2019 to advance its therapies to treat late-stage and metastatic cancers, including breast, pancreatic, colorectal, brain and kidney.
We wish Dr. Mark Esposito and Dr. Yibin Kang continued success as they advance their technology toward a product that will significantly impact the global health of patients with late-stage cancer.
Innovation Grants Awarded
Congratulations to the most recent Innovation Grant recipients in the Foundation for Health Advancement's Innovation Grant Program!
The exciting projects funded were:
S. Petry, PhD "Treating and Curing Cancer"
T. Keck, PhD & G. Moura-Letts, PhD "Analgesics without Addiction"
J. Kim, PhD "Minimally Invasive Palpation Device"
S. Shady, PhD "Trach Alert Project"
QED Program Grant Recipients
Congratulations to Maksim Mezhericher and Professor Howard Stone from Princeton University for being selected as grant recipients of the University City Science Center's QED Proof-of-Concept program! They are working hard to discover solutions to storing vaccines and biologics at room temperature. With this grant, they are one step closer to "thawing the cold chain!"
The recipients are currently part of our Innovation Grant Program.